3biotech.com
Nextbiotix chose 3Biotech to help them bring their drug candidate, NBX1650, to first in man. - 3Biotech
Nextbiotix is a preclinical stage biotechnology company developing mono Live Biotherapeutics involved in inflammatory bowel diseases. NBX1650, is a mono-strain microbial product candidate using Faecalibacterium …